ProSomnus, Inc. (OSAPW) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
5675 GIBRALTAR DR PLEASANTON, CA 94588 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,477 | 6,363 | 12,022 | 6,176 | 11,560 | ||||
| Cash and cash equivalent | 3,477 | 6,363 | 12,022 | 6,176 | 11,560 | ||||
| Restricted cash and investments | 700 | 700 | |||||||
| Receivables | 4,339 | 3,839 | 3,443 | 3,561 | 2,663 | ||||
| Inventory, net of allowances, customer advances and progress billings | 2,023 | 2,039 | 1,650 | 1,310 | 758 | ||||
| Inventory | 2,023 | 2,039 | 1,650 | 1,310 | 758 | ||||
| Other undisclosed current assets | 1,111 | 1,369 | 558 | 1,163 | 1,571 | ||||
| Total current assets: | 11,650 | 14,310 | 17,673 | 12,209 | 16,552 | ||||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 3,603 | 3,265 | 3,532 | 4,165 | 3,470 | ||||
| Operating lease, right-of-use asset | 4,981 | 5,069 | 5,154 | 5,239 | 5,305 | ||||
| Property, plant and equipment | 3,166 | 3,358 | 3,740 | 3,266 | 2,995 | ||||
| Other noncurrent assets | 479 | 285 | 284 | 346 | 263 | ||||
| Total noncurrent assets: | 12,229 | 11,977 | 12,710 | 13,015 | 12,033 | ||||
| TOTAL ASSETS: | 23,879 | 26,287 | 30,383 | 25,224 | 28,585 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,178 | 10,803 | 10,121 | 7,897 | 6,216 | ||||
| Accounts payable | 4,532 | 4,047 | 1,748 | 2,072 | 1,310 | ||||
| Accrued liabilities | 5,646 | 6,756 | 8,373 | 5,824 | 4,907 | ||||
| Debt | 1,176 | 1,109 | 1,165 | 1,282 | 956 | ||||
| Other undisclosed current liabilities | 27,603 | 2,429 | 291 | 278 | 330 | ||||
| Total current liabilities: | 38,957 | 14,341 | 11,578 | 9,456 | 7,502 | ||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2,369 | 2,138 | 2,370 | 2,648 | 2,090 | ||||
| Long-term debt, excluding current maturities | 113 | 129 | 143 | 167 | 172 | ||||
| Finance lease, liability | 2,256 | 2,009 | 2,227 | 2,481 | 1,918 | ||||
| Liabilities, other than long-term debt | 5,134 | 5,221 | 5,268 | 5,377 | 5,452 | ||||
| Operating lease, liability | 5,134 | 5,221 | 5,268 | 5,377 | 5,452 | ||||
| Other undisclosed noncurrent liabilities | 168 | 31,188 | 32,870 | 33,491 | 40,701 | ||||
| Total noncurrent liabilities: | 7,671 | 38,547 | 40,509 | 41,516 | 48,244 | ||||
| Total liabilities: | 46,628 | 52,888 | 52,086 | 50,973 | 55,746 | ||||
| Temporary equity, including noncontrolling interest | 11,555 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | (34,304) | (38,156) | (33,368) | (25,749) | (27,160) | ||||
| Common stock | 2 | 2 | 2 | 2 | 2 | ||||
| Additional paid in capital | 197,142 | 196,731 | 194,651 | 191,032 | 190,525 | ||||
| Accumulated deficit | (231,448) | (234,889) | (228,021) | (216,782) | (217,687) | ||||
| Other undisclosed equity | 11,555 | 11,665 | |||||||
| Total equity: | (34,304) | (26,601) | (21,703) | (25,749) | (27,160) | ||||
| TOTAL LIABILITIES AND EQUITY: | 23,879 | 26,287 | 30,383 | 25,224 | 28,585 | ||||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7,458 | 7,838 | 7,071 | 6,934 | 5,808 | |||
| Cost of revenue | (3,833) | (4,134) | (3,580) | (3,171) | (2,757) | |||
| Gross profit: | 3,625 | 3,705 | 3,491 | 3,763 | 3,052 | |||
| Operating expenses | (5,416) | (8,715) | (7,707) | (9,499) | (7,196) | |||
| Operating loss: | (1,791) | (5,010) | (4,216) | (5,736) | (4,144) | |||
| Nonoperating income (expense) | 5,232 | (1,859) | (7,023) | 6,641 | (2,748) | |||
| Other nonoperating income (expense) | (55) | 2,395 | (3,964) | (123) | (407) | |||
| Interest and debt expense | (1,146) | (707) | (9,743) | (1,240) | (1,172) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | 2,295 | (7,576) | (20,982) | (335) | (8,064) | |||
| Other undisclosed income (loss) from continuing operations before income taxes | (9,743) | 9,743 | 1,240 | 1,172 | ||||
| Income (loss) from continuing operations: | 2,295 | (17,319) | (11,239) | 905 | (6,892) | |||
| Other undisclosed net income | 1,146 | 10,450 | ||||||
| Net income (loss): | 3,441 | (6,869) | (11,239) | 905 | (6,892) | |||
| Other undisclosed net loss attributable to parent | ||||||||
| Net income (loss) available to common stockholders, basic: | 3,441 | (6,869) | (11,239) | 905 | (6,892) | |||
| Interest on convertible debt | 4,931 | |||||||
| Dilutive securities, effect on basic earnings per share | (1,168) | |||||||
| Other undisclosed net loss available to common stockholders, diluted | (9,862) | |||||||
| Net loss available to common stockholders, diluted: | (1,490) | (6,869) | (11,239) | (263) | (6,892) | |||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 3,441 | (6,869) | (11,239) | 905 | (6,892) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | 3,441 | (6,869) | (11,239) | 905 | (6,892) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.